Biosensors for breast cancer diagnosis: A review of bioreceptors, biotransducers and signal amplification strategies
Breast cancer is highly prevalent in females and accounts for second highest number of
deaths, worldwide. Cumbersome, expensive and time consuming detection techniques …
deaths, worldwide. Cumbersome, expensive and time consuming detection techniques …
[HTML][HTML] Mass spectrometry-assisted gel-based proteomics in cancer biomarker discovery: approaches and application
R Huang, Z Chen, L He, N He, Z Xi, Z Li, Y Deng… - Theranostics, 2017 - ncbi.nlm.nih.gov
There is a critical need for the discovery of novel biomarkers for early detection and targeted
therapy of cancer, a major cause of deaths worldwide. In this respect, proteomic …
therapy of cancer, a major cause of deaths worldwide. In this respect, proteomic …
Breast cancer biomarker detection through the photoluminescence of epitaxial monolayer MoS2 flakes
S Catalán-Gómez, M Briones, S Cortijo-Campos… - Scientific Reports, 2020 - nature.com
In this work we report on the characterization and biological functionalization of 2D MoS2
flakes, epitaxially grown on sapphire, to develop an optical biosensor for the breast cancer …
flakes, epitaxially grown on sapphire, to develop an optical biosensor for the breast cancer …
An electrochemical aptasensor based on gold nanoparticles and graphene oxide doped poly (3, 4-ethylenedioxythiophene) nanocomposite for detection of MUC1
In the present work, we have developed an electrochemical aptasensor for detection of
breast cancer biomarker protein, mucin1 (MUC1). Gold nanoparticles (AuNPs) and …
breast cancer biomarker protein, mucin1 (MUC1). Gold nanoparticles (AuNPs) and …
Enhanced aptasensor performance for targeted HER2 breast cancer detection by using screen-printed electrodes modified with Au nanoparticles
T Harahsheh, YF Makableh, I Rawashdeh… - Biomedical …, 2021 - Springer
The development of an Aptamer based biosensor for the selective detection of human
epidermal growth factor receptor 2 (HER2) with high sensitivity and specificity was achieved …
epidermal growth factor receptor 2 (HER2) with high sensitivity and specificity was achieved …
Amperometric magnetoimmunosensor for ErbB2 breast cancer biomarker determination in human serum, cell lysates and intact breast cancer cells
U Eletxigerra, J Martinez-Perdiguero, S Merino… - Biosensors and …, 2015 - Elsevier
A highly sensitive amperometric magnetoimmunosensor for the determination of ErbB2
protein, a well-known biomarker related to high-impact high-incidence diseases such as …
protein, a well-known biomarker related to high-impact high-incidence diseases such as …
Design and optimization of refractive index biosensor for MDA-MB-231 and MCF-7 breast cancer biomarker detection
Breast cancer is the leading malignancy in women and the 2nd widespread cancer globally.
Earlier identification of breast cancer can improve treatment outcomes and prevent …
Earlier identification of breast cancer can improve treatment outcomes and prevent …
Inhibition of sirtuin 1 deacetylase by miR-211-5p provides a mechanism for the induction of cell death in breast cancer cells
Sirtuin 1 is one of the regulators of cell growth and survival and its inhibition is suggested as
a suitable mechanism to overcome breast cancer development. In this study we explored the …
a suitable mechanism to overcome breast cancer development. In this study we explored the …
Detection of soluble ERBB2 in breast cancer cell lysates using a combined label-free/fluorescence platform based on Bloch surface waves
We report on the use of one-dimensional photonic crystals to detect clinically relevant
concentrations of ERBB2/neu/Her2 in cell lysates. ERBB2 is a pivotal breast cancer …
concentrations of ERBB2/neu/Her2 in cell lysates. ERBB2 is a pivotal breast cancer …
Quantification of circulating cancer biomarkers via sensitive topographic measurements on single binder nanoarrays
E Ambrosetti, P Paoletti, A Bosco, P Parisse… - ACS …, 2017 - ACS Publications
Early detection of cancer plays a crucial role in disease prognosis. It requires the recognition
and quantification of low amounts of specific molecular biomarkers, either free or transported …
and quantification of low amounts of specific molecular biomarkers, either free or transported …